Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- VANOS Cream and Skin Barrier Function: Complete Statistical AnalysisIndependent statistical analysis of VANOS Cream and Skin Barrier Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00819507).
- Varenicline to Reduce Alcohol Consumption in Heavy Drinkers: Complete Statistical AnalysisIndependent statistical analysis of Varenicline to Reduce Alcohol Consumption in Heavy Drinkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00695500).
- Variability and Specificity in Reactive Stabilization Movements to Diverse Slip Perturbations: Complete Statistical AnalysisIndependent statistical analysis of Variability and Specificity in Reactive Stabilization Movements to Diverse Slip Perturbations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VARSUDIndependent statistical analysis of Varenicline and Motivational Advice for Smokers With Substance Use Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756275).
- Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.: Complete Statistical AnalysisIndependent statistical analysis of Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo: Complete Statistical AnalysisIndependent statistical analysis of Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vashe Wound Therapy Study: Complete Statistical AnalysisIndependent statistical analysis of Vashe Wound Therapy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00586729).
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaspect Study – An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia: Complete Statistical AnalysisIndependent statistical analysis of Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VASSTIndependent statistical analysis of An Exploratory Clinical Study on a Variable Speed and Sensing Treadmill System (VASST) for Hemiparetic Gait Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- VASTIndependent statistical analysis of Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05319561).
- VATIndependent statistical analysis of Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination: Complete Statistical AnalysisIndependent statistical analysis of VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05570630).
- VAXCHORA Pediatric Study to Assess Safety and Immunogenicity: Complete Statistical AnalysisIndependent statistical analysis of VAXCHORA Pediatric Study to Assess Safety and Immunogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03220737).
- VB-111 in Surgically Accessible Recurrent/Progressive GBM: Complete Statistical AnalysisIndependent statistical analysis of VB-111 in Surgically Accessible Recurrent/Progressive GBM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04406272).
- VC01-103Independent statistical analysis of A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VEC-162 Study in Adult Patients With Primary Insomnia: Complete Statistical AnalysisIndependent statistical analysis of VEC-162 Study in Adult Patients With Primary Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00548340).
- VECTORIndependent statistical analysis of Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VECTORIndependent statistical analysis of Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VECTORIndependent statistical analysis of Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Vector Efficacy Cross-Over Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Vector Efficacy Cross-Over Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04263532).
- Vector Engineering Clinical: Complete Statistical AnalysisIndependent statistical analysis of Vector Engineering Clinical: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04725500).
- VEGAIndependent statistical analysis of Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02396316).
- VEGA-1Independent statistical analysis of Norepinephrine vs Phenylephrine During General Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04789330).
- VEGA-2Independent statistical analysis of Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia: primary endpoint results, effect estimate with…
- VEGA-3Independent statistical analysis of Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VELIAIndependent statistical analysis of Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal…
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect…
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04067011).
- VELOCITY: An Anthrax Vaccine Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of VELOCITY: An Anthrax Vaccine Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03877926).
- VELOURIndependent statistical analysis of the phase 3 VELOUR trial of aflibercept plus FOLFIRI versus placebo plus FOLFIRI in metastatic colorectal cancer after failure of an oxaliplatin-based regimen, including trial design, survival analysis,…
- VELVETIndependent statistical analysis of A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor…
- VeLVETIndependent statistical analysis of Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02691936).
- Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma: Complete Statistical AnalysisIndependent statistical analysis of Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vemurafenib and TIL Therapy for Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Vemurafenib and TIL Therapy for Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354690).
- Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VENICEIndependent statistical analysis of Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VENICE IIIndependent statistical analysis of A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer…
- Venlafaxine 25 mg Tablets Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Venlafaxine 25 mg Tablets Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00834249).
- Ventilation Strategy During General Anesthesia for Orthopedic Surgery: A Quality Improvement Project: Complete Statistical AnalysisIndependent statistical analysis of Ventilation Strategy During General Anesthesia for Orthopedic Surgery: A Quality Improvement Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- VENUSIndependent statistical analysis of Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VEPSCIndependent statistical analysis of Vaccination Education Through Pharmacists and Senior Centers (VEPSC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03239665).
- VERITASIndependent statistical analysis of A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal…
- VERITASIndependent statistical analysis of Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary: primary endpoint…
- Vessel Sparing Prostate Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Vessel Sparing Prostate Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02958787).
- Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01021137).
- Vet-COACHIndependent statistical analysis of Veteran Peer Coaches Optimizing and Advancing Cardiac Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02697422).
- VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2: Complete Statistical AnalysisIndependent statistical analysis of VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative…